查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908147

介入性肿瘤学市场规模、份额和趋势分析报告：按技术、手术、适应症、最终用途、地区和细分市场预测，2026-2033年

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique, By Procedures, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10个工作天内

价格

介入性肿瘤学市场概述

全球介入性肿瘤学市场预计到 2025 年将价值 29 亿美元，预计到 2033 年将达到 56.1 亿美元。

预计从 2026 年到 2033 年，该行业将以 8.59% 的复合年增长率成长。这一增长可归因于癌症发病率的上升、微创手术技术的进步、人口老化加剧、对癌症早期检测的日益重视，以及公共和私人对介入性肿瘤学领域的投资不断增加。

全球癌症病例数量正显着增加，这促使人们迫切需要能够改善癌症治疗的先进解决方案。根据世界卫生组织统计，2022年全球新增癌症病例约2,000万例，死亡病例约970万例。预计到2050年，病例数将超过3,500万例，全球癌症负担将增加77%。介入性肿瘤学涵盖多种微创治疗技术，包括射频消融术（RFA）、经动脉化疗栓塞术（TACE）和冷冻疗法，这些技术相比传统手术具有显着优势，例如恢復时间更短、併发症发生率更低。随着全球癌症负担的持续加重，这些先进的介入技术有望得到更广泛的应用，因为它们能够改善患者的治疗效果和生活品质。

全球癌症发生率的上升主要归因于吸烟率的增加、不健康的饮食习惯、饮酒、空气污染以及缺乏运动。癌症病例的激增给医疗保健系统带来了巨大挑战，促使人们开发能够提供更佳治疗效果和预后的先进解决方案。介入性肿瘤学作为一种微创疗法，正日益受到欢迎，成为传统癌症治疗（如手术、放射疗法和化疗）的替代方案。减轻患者负担和缩短復原时间是推动市场成长的主要因素。

这些令人警醒的统计数据凸显了有效癌症治疗方法的迫切需求。介入性肿瘤学，包括射频消融术（RFA）、经动脉化疗栓塞术（TACE）和冷冻疗法（冷冻消融术）等多种微创技术，与传统手术相比具有显着优势，例如恢復时间更短、併发症发生率更低。随着全球癌症负担的持续加重，我们预计这些先进的介入技术将加速应用，因为它们能够改善患者的预后和生活品质。

介入肿瘤学市场的企业正积极寻求各种策略，以开发旨在改善患者治疗和护理的先进解决方案。例如，2021年4月，Terumo Corporation）成立了全球治疗性介入肿瘤学团队，致力于追求卓越的介入性肿瘤学解决方案，提高患者的生活品质和存活率。这些努力有望促进创新解决方案的开发，并推动介入肿瘤学的普及和市场成长。

此外，为开发先进解决方案而加大投入，正促使政府和私人机构进行大量投资。 2023年6月，皇家飞利浦宣布，其协调的临床合作伙伴联盟IMAGIO Consortium已获得约2,597万美元的津贴。这笔资金将用于支持微创癌症治疗的研究，并着重于肝癌、肺癌和软组织肉瘤。此类投资对于推进介入肿瘤学技术和改善患者预后至关重要。

目录

第一章调查方法和范围

第二章执行摘要

3.介入肿瘤学市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 介入性肿瘤学市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
    • 新冠疫情影响分析

第四章 介入性肿瘤学市场：依技术分類的估计与趋势分析

  • 全球介入性肿瘤学市场：技术变革分析
  • 全球介入性肿瘤市场规模及趋势分析（依技术划分，2021-2033年）
  • 消融疗法
    • 射频消融术（RFA）
    • 微波消融术（MWA）
    • 冷冻消融术
    • 雷射消熔
    • 不可逆电穿孔（IRE）
  • 栓塞治疗
    • 经动脉化疗栓塞术（TACE）
    • 经动脉放射性栓塞术（TARE）
  • 切片检查技术
    • 核心针穿刺切片
    • 细针穿刺细胞学检查（FNA）
  • 标靶治疗递送系统
    • 药物释放型微珠
    • 放射性栓塞
    • 药物释放型支架
    • 可注射水凝胶奈米颗粒
    • 其他的
  • 影像导引手术
    • 超音波引导
    • 电脑断层扫描指南
    • MRI 指南
    • 透视指南

第五章 介入性肿瘤学市场：依手术类型分類的估计与趋势分析

  • 全球介入性肿瘤学市场：依手术方式分類的差异分析
  • 全球介入性肿瘤学市场规模及趋势分析（依手术类型划分），2021-2033年
  • 肿瘤消融
  • 肿瘤切片检查
  • 血管介入治疗
  • 安宁疗护

第六章：介入性肿瘤学市场：依适应症分類的估算与趋势分析

  • 全球介入性肿瘤学市场：按适应症分類的差异分析
  • 全球介入性肿瘤学市场规模及趋势分析（依适应症划分，2021-2033年）
  • 肝癌
  • 肺癌
  • 肾癌
  • 摄护腺癌
  • 乳癌
  • 其他的

第七章 介入性肿瘤学市场：依最终用途分類的估算与趋势分析

  • 全球介入性肿瘤学市场：按最终用途分類的差异分析
  • 全球介入性肿瘤学市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 医院
  • 专科诊所
  • 其他的

第八章：介入性肿瘤学市场：区域估算与趋势分析

  • 2023年及2030年区域市占率分析
  • 区域市场概览
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2023年商业市场分析
  • 公司简介/列表
    • Medtronic plc
    • Boston Scientific Corporation
    • Johnson &Johnson（Ethicon）
    • Baxter International Inc.
    • Cook Medical
    • CR Bard Inc.（Acquired by BD）
    • AngioDynamics Inc.
    • Stryker Corporation
    • B. Braun Melsungen AG
    • Terumo Corporation
    • Siemens Healthineers
    • GE Healthcare
Product Code: GVR-4-68040-363-1

Interventional Oncology Market Summary

The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology.

There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care according to WHO, in 2022, approximately 20 million new cancer cases and 9.7 million deaths occurred. By 2050, cases are projected to rise to over 35 million, marking a 77% increase in the global cancer burden.Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

The rising global incidence of cancer is largely attributed to increasing tobacco use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative to traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.

These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

Companies in the interventional oncology market are actively pursuing various strategies to develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terumo launched its global therapeutic interventional oncology team to achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected to spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.

Moreover, increased efforts to develop advanced solutions have led to significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately USD 25.97 million. This funding is intended to support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.

Global Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 - 2033. For this study, Grand View Research has segmented the global interventional oncology market report based on technique, procedures, application, end-use, and region:

  • Techniques Outlook (Revenue, USD Million, 2021 - 2033)
  • Ablation Therapies
    • Radiofrequency Ablation (RFA)
    • Microwave Ablation (MWA)
    • Cryoablation
    • Laser Ablation
    • Irreversible Electroporation (IRE)
  • Embolization Therapies
    • Transarterial Chemoembolization (TACE)
    • Transarterial Radioembolization (TARE)
  • Biopsy Techniques
    • Core Needle Biopsy
    • Fine Needle Aspiration (FNA)
  • Targeted Therapy Delivery Systems
    • Drug-Eluting Beads
    • Radioembolization
    • Drug-Eluting Stents
    • Injectable Hydrogels and Nanoparticles
    • Other Targeted Therapy Systems
  • Image-Guided Procedures
    • Ultrasound Guidance
    • CT Scan Guidance
    • MRI Guidance
    • Fluoroscopy Guidance
  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Breast Cancer
  • Other Cancer
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technique Segment
    • 1.2.2. Procedure Segment
    • 1.2.3. Application Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Interventional Oncology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Increasing technological advancements in minimally invasive procedures
      • 3.2.1.3. Growing geriatric population
      • 3.2.1.4. Increasing focus on early cancer detection
      • 3.2.1.5. Increasing public and private investments in the field of interventional oncology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with interventional oncology
      • 3.2.2.2. Requirement of highly skilled professionals
  • 3.3. Interventional Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Interventional Oncology Market: Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Interventional Oncology Market Technique Movement Analysis
  • 4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2021 - 2033 (USD Million)
  • 4.4. Ablation Therapies
    • 4.4.1. Ablation Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Radiofrequency Ablation (RFA)
      • 4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Microwave Ablation (MWA)
      • 4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Cryoablation
      • 4.4.4.1. Cryoablation market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Laser Ablation
      • 4.4.5.1. Laser Ablation market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Irreversible Electroporation (IRE)
      • 4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Embolization Therapies
    • 4.5.1. Embolization Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transarterial Chemoembolization (TACE)
      • 4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Transarterial Radioembolization (TARE)
      • 4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Biopsy Techniques
    • 4.6.1. Biopsy Techniques market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Core Needle Biopsy
      • 4.6.2.1. Core Needle Biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Fine Needle Aspiration (FNA)
      • 4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Targeted Therapy Delivery Systems
    • 4.7.1. Drug Delivery Systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Drug-Eluting Beads
      • 4.7.2.1. Drug-Eluting Beads market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Radioembolization
      • 4.7.3.1. Radioembolization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Drug-Eluting Stents
      • 4.7.4.1. Drug-Eluting Stents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Injectable Hydrogels and Nanoparticles
      • 4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.6. Other Targeted Therapy Systems
      • 4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Image-Guided Procedures
    • 4.8.1. Image-Guided Procedures market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. Ultrasound Guidance
      • 4.8.2.1. Ultrasound Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. CT Scan Guidance
      • 4.8.3.1. CT Scan Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.4. MRI Guidance
      • 4.8.4.1. MRI Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.5. Fluoroscopy Guidance
      • 4.8.5.1. Fluoroscopy Guidance market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Interventional Oncology Market: Procedures Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Interventional Oncology Market Procedures Movement Analysis
  • 5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedure, 2021 - 2033 (USD Million)
  • 5.4. Tumor Ablation
    • 5.4.1. Tumor Ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Tumor Biopsy
    • 5.5.1. Tumor Biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Vascular Interventions
    • 5.6.1. Vascular Interventions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Palliative Care
    • 5.7.1. Palliative Care market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Interventional Oncology Materials Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Interventional Oncology Market Application Movement Analysis
  • 6.3. Global Interventional Oncology Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
  • 6.4. Liver Cancer
    • 6.4.1. Liver Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Lung Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Kidney Cancer
    • 6.6.1. Kidney Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Prostate Cancer
    • 6.7.1. Prostate Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Breast Cancer
    • 6.8.1. Breast Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Other Cancer
    • 6.9.1. Other Cancer market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Interventional Oncology Market: End use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Interventional Oncology Market End Use Movement Analysis
  • 7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Interventional Oncology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 - 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. U.S. market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Canada market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Mexico market estimates and forecasts 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. UK market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. Germany market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. France market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Italy market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Spain market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Norway market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Sweden market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Denmark market estimates and forecasts 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Japan market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. China market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. India market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. Australia market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Reimbursement scenario
      • 8.6.6.4. Regulatory framework
      • 8.6.6.5. Thailand market estimates and forecasts 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. Brazil market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Argentina market estimates and forecasts 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. Reimbursement scenario
      • 8.8.1.5. South Africa market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. UAE market estimates and forecasts 2021 - 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Medtronic plc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Boston Scientific Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Johnson & Johnson (Ethicon)
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Baxter International Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Cook Medical
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. C.R. Bard Inc. (Acquired by BD)
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. AngioDynamics Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Stryker Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. B. Braun Melsungen AG
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Terumo Corporation
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Siemens Healthineers
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. GE Healthcare
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global interventional oncology market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 4 Global interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 5 Global interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 7 North America interventional oncology market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 9 North America interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 10 North America interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 12 U.S. interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 13 U.S. interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 14 U.S. interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 15 U.S. interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 16 Canada interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 17 Canada interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 18 Canada interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 19 Canada interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 20 Mexico interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 21 Mexico interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 22 Mexico interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 23 Mexico interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 24 Europe interventional oncology market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 26 Europe interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 27 Europe interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 28 Europe interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 29 Germany interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 30 Germany interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 31 Germany interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 32 Germany interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 33 UK interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 34 UK interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 35 UK interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 36 UK interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 37 France interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 38 France interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 39 France interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 40 France interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 41 Italy interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 42 Italy interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 43 Italy interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 44 Italy interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 45 Spain interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 46 Spain interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 47 Spain interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 48 Spain interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 49 Denmark interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 50 Denmark interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 51 Denmark interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 52 Denmark interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 53 Sweden interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 54 Sweden interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 55 Sweden interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 56 Sweden interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 57 Norway interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 58 Norway interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 59 Norway interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 60 Norway interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific interventional oncology market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 66 China interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 67 China interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 68 China interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 69 China interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 70 Japan interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 71 Japan interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 72 Japan interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 73 Japan interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 74 India interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 75 India interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 76 India interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 77 India interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 78 South Korea interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 79 South Korea interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 80 South Korea interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Korea interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 82 Australia interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 83 Australia interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 84 Australia interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 85 Australia interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 86 Thailand interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 87 Thailand interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 88 Thailand interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 89 Thailand interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 90 Latin America interventional oncology market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 92 Latin America interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 93 Latin America interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 94 Latin America interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 95 Brazil interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 96 Brazil interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 97 Brazil interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 98 Brazil interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 99 Argentina interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 100 Argentina interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 101 Argentina interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 102 Argentina interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 103 MEA interventional oncology market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 105 MEA interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 106 MEA interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 107 MEA interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 108 South Africa interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 109 South Africa interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 110 South Africa interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Africa interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 116 UAE interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 117 UAE interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 118 UAE interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 119 UAE interventional oncology market, by End use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait interventional oncology market, by technique, 2021 - 2033 (USD Million)
  • Table 121 Kuwait interventional oncology market, by procedure, 2021 - 2033 (USD Million)
  • Table 122 Kuwait interventional oncology market, by application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait interventional oncology market, by End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Interventional Oncology market: Market outlook
  • Fig. 5 Interventional Oncology market: Segment outlook
  • Fig. 6 Interventional Oncology market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Interventional Oncology market driver impact
  • Fig. 9 Interventional Oncology market restraint impact
  • Fig. 10 Interventional Oncology market: Technique outlook and key takeaways
  • Fig. 11 Interventional Oncology market: Technique movement analysis
  • Fig. 12 Ablation Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Radiofrequency Ablation (RFA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Microwave Ablation (MWA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Cryoablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Laser Ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Irreversible Electroporation (IRE) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Embolization Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Transarterial Chemoembolization (TACE) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Transarterial Radioembolization (TARE) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Biopsy Techniques market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Core Needle Biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Fine Needle Aspiration (FNA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Targeted Therapy Delivery Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Drug-Eluting Beads market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Radioembolization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Drug-Eluting Stents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Other Targeted Therapy Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Image-Guided Procedures market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Ultrasound Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 CT Scan Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 MRI Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Fluoroscopy Guidance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Interventional Oncology market: Procedure outlook and key takeaways
  • Fig. 36 Interventional Oncology market: Procedure movement analysis
  • Fig. 37 Tumor Ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Tumor Biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Vascular Interventions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Palliative Care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Interventional Oncology market: Application outlook and key takeaways
  • Fig. 42 Interventional Oncology market: Application movement analysis
  • Fig. 43 Liver Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Lung Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Kidney Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Prostate Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Breast Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Other Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Interventional Oncology market: End use outlook and key takeaways
  • Fig. 50 Interventional Oncology market: End use movement analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Specialty Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Other market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Global Interventional Oncology market: Regional outlook and key takeaways
  • Fig. 56 Global Interventional Oncology market: Regional movement analysis
  • Fig. 57 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Target Disease Prevalence
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)